AptarGroup, Inc. (ATR)
Largest Insider Buys in Sector
ATR Stock Price History Chart
ATR Stock Performance
About AptarGroup, Inc.
AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable …
Insider Activity of AptarGroup, Inc.
Over the last 12 months, insiders at AptarGroup, Inc. have bought $0 and sold $28.64M worth of AptarGroup, Inc. stock.
On average, over the past 5 years, insiders at AptarGroup, Inc. have bought $299,504 and sold $15.35M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,170 shares for transaction amount of $299,504 was made by Trerotola Matthew L. (director) on 2022‑11‑03.
List of Insider Buy and Sell Transactions, AptarGroup, Inc.
| 2024-11-15 | Sale | EVP and Chief Legal Officer | 964 0.0014% | $168.83 | $162,752 | |||
| 2024-11-12 | Sale | Segment President | 852 0.0013% | $175.79 | $149,770 | -2.68% | ||
| 2024-10-29 | Sale | Segment President | 4,000 0.006% | $168.28 | $673,136 | +2.64% | ||
| 2024-10-28 | Sale | President and CEO | 30,000 0.0462% | $169.60 | $5.09M | -0.53% | ||
| 2024-09-13 | Sale | Segment President | 1,375 0.0021% | $152.54 | $209,745 | +9.04% | ||
| 2024-09-09 | Sale | Segment President | 3,300 0.005% | $151.62 | $500,338 | +6.03% | ||
| 2024-08-29 | Sale | Segment President | 3,500 0.0053% | $152.31 | $533,085 | +5.02% | ||
| 2024-08-26 | Sale | EVP & CFO | 1,000 0.0015% | $151.29 | $151,287 | +6.35% | ||
| 2024-08-26 | Sale | Chief Human Resources Officer | 1,660 0.0025% | $151.15 | $250,905 | +6.35% | ||
| 2024-08-23 | Sale | EVP & CFO | 49,463 0.0743% | $149.97 | $7.42M | +6.00% | ||
| 2024-08-22 | Sale | EVP & CFO | 200 0.0003% | $150.18 | $30,036 | +6.87% | ||
| 2024-08-15 | Sale | President, Asia | 7,200 0.0111% | $146.52 | $1.05M | 0.00% | ||
| 2024-08-13 | Sale | director | 1,922 0.0029% | $144.43 | $277,603 | 0.00% | ||
| 2024-08-07 | Sale | President, Asia | 800 0.0012% | $146.56 | $117,252 | +10.50% | ||
| 2024-07-29 | Sale | President and CEO | 32,000 0.0482% | $147.56 | $4.72M | +5.52% | ||
| 2024-06-06 | Sale | EVP and Chief Legal Officer | 825 0.0013% | $146.77 | $121,086 | +3.95% | ||
| 2024-05-07 | Sale | Segment President | 3,200 0.0048% | $148.92 | $476,538 | -0.47% | ||
| 2024-05-01 | Sale | Segment President | 4,634 0.007% | $145.09 | $672,344 | +2.55% | ||
| 2024-03-12 | Sale | director | 2,000 0.003% | $142.45 | $284,906 | +3.49% | ||
| 2024-03-11 | Sale | Segment President | 3,500 0.0053% | $142.84 | $499,932 | +3.19% |
Insider Historical Profitability
| Tanda Stephan B. | President and CEO | 174118 0.2617% | $168.56 | 1 | 3 | +13.88% |
| CHEVASSUS ALAIN | director | 15896 0.0239% | $168.56 | 1 | 6 | +22.89% |
| Wunderlich Ralf K. | director | 7465 0.0112% | $168.56 | 1 | 5 | +7.37% |
| FOTIADES GEORGE L | director | 4962 0.0075% | $168.56 | 1 | 4 | +7.59% |
| GOLDSTEIN RODNEY L | director | 4500 0.0068% | $168.56 | 2 | 0 | +18.82% |
Institutional Investor Ownership
| The Vanguard Group | $1.03B | 10.81 | 7.16M | +0.07% | +$748,084.11 | 0.02 | |
| BlackRock | $877.86M | 9.21 | 6.1M | +0.46% | +$4.06M | 0.02 | |
| Morgan Stanley | $721.29M | 7.57 | 5.01M | +1.88% | +$13.28M | 0.05 | |
| State Farm | $682.7M | 7.16 | 4.74M | 0% | +$0 | 0.62 | |
| State Street | $427.7M | 4.49 | 2.97M | -2.7% | -$11.87M | 0.02 |